In this frame, the PTX3-derived small molecule FGF-trap NSC12 may pave the way to the discovery of novel drug candidates for those subsets of soft tissue sarcomas, including fibrosarcomas, in which FGFR ligands play an onco-driving role. The gene discussed is PTX3; the disease is soft tissue sarcoma.